Hepatitis C Treatment May Cost New Jersey MillionsJanuary 14, 2003 Ten weeks after pledging to pay for treating the hepatitis C epidemic in its prisons, New Jersey has learned how much it may cost -- $4.5 million to $8 million this year, by conservative estimates. The prison medical provider, Correctional Medical Services of St. Louis, projected the cost.
Adapted from:The CMS documents, obtained by the Inquirer through the state's Open Public Records Act, said one-fourth of New Jersey's 26,000 inmates would probably test positive for hepatitis C if the prison system decided to screen everyone for the virus. In July, the Inquirer reported that New Jersey prisons were not treating inmates with the disease, which can lead to liver failure. CMS also did not tell hundreds of inmates that they had tested positive for hepatitis C, including 21 who had been released. The hepatitis C epidemic has hit prisons across the country, but only a handful of states pay for extensive screening and treatment. In July, New Jersey was treating only one inmate, although 1,170 already had tested positive for the virus. The state this year is paying CMS nearly $100 million for prison medical care. That does not include the cost of hepatitis C treatment, which the state started covering Nov. 1. As of Dec. 4, new documents show, 1,407 inmates were known to be infected -- a 20 percent increase in five months. Corrections Commissioner Devon Brown said he expects the numbers to climb as inmates and medical staff learn more about the disease and more prisoners ask to be tested. Back to other CDC news for January 14, 2003 Philadelphia Inquirer 01.12.03; Mark Fazlollah; Jennifer Lin This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |